Hexaphoenix offer branded generic products in different development stages. By developing and manufacturing the majority of our products to make it readily available eCTD dossiers Licensing with supply from our European R & D Facilities.
We offer the products which are developed and manufactured to UK medicines and Healthcare Regulatory Agency (MHRA) and EUGMP standards. All of molecules have Marketing Authorizations issued by the MHRA and EU Authorities with Certificate of Pharmaceutical Product (CPP) available.
– List of EU and UK products
For more detailed information on our products please contact us!
Strength: 100mg /200mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 75mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250mg /500mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 1.25mg /2.5mg/3.75mg/5mg/7.5mg/10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg/20mg/30mg/40mg/60mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD / ACTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 30mg/60mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 40/160mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 500mg/750mg/1000mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: Prochlorperazine |Â Tablet |Â 5mg
Prochlorperazine (OTC) | Buccal Tablet | 3mg
Prochlorperazine (Prescription Only) | Buccal Tablet | 3mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 7.5mg/5ml, 30mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5/10/20/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 375mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD / ACTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 800mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5mg / 7.5mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 30 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 50/100mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 12.5/25/50/100mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 0.5mg / 0.75mg / 1.0mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg + 125mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg + 125mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg
Dosage: ODT (Lingual) Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 8mg /16mg / 24mg /48mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 0.5mg / ml
Dosage: Oral Solution
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 500 mg / 1000mg
Dosage: Granules in Sachet
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 1mg/5mg/10mg
Dosage: Film Coated Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 62.5 mcg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 5 IU and 10 IU
Dosage: Injection
Approved Authority: WHO Prequalified and From EUGMP Approved Plant
Dossiers Available: Ready CTD
Bioequivalence (BE/BA) study: Not Required for Injection
Market Availability: Not available for Ghana, Tanzania, Vietnam, Sri Lanka.